Overexpression of survivin correlates with reduced remission rates and survival in pediatric patients with acute lymphoblastic leukemia, adult patients with acute myeloid leukemia and adult T cell leukemia, as well as diffuse large B cell lymphoma [9, 28, 29]. This evidence concerns the gene BIRC5 and acute myeloid leukemia.